Clinical trial
Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute…
NCT00016016 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00016016 |
|---|---|
| Title | Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia |
| Official title | A Phase I/II Study of Flavopiridol (NSC 649890, IND 46,211) in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Poor-Risk Acute Leukemias |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia |
| Intervention type | Drug, Other |
| Interventions | cytarabine, mitoxantrone hydrochloride, alvocidib, pharmacological study, laboratory procedure |
| Enrollment | 53 |
| Start date | Feb 1, 2001 |
| Primary completion | Nov 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: